Death
Dante Paul Lacourte died on April 7, 2026, at the age of sixteen, in the apartment on Bush Street in San Francisco's Lower Nob Hill neighborhood that he shared with his mother, Christina Lacourte. She went to wake him that morning and found him unresponsive, his face discolored and his veins visibly pronounced. She administered two doses of Narcan, the…
Dante Paul Lacourte died on April 7, 2026, at the age of sixteen, in the apartment on Bush Street in San Francisco's Lower Nob Hill neighborhood that he shared with his mother, Christina Lacourte. She went to wake him that morning and found him unresponsive, his face discolored and his veins visibly pronounced. She administered two doses of Narcan, the brand name for the overdose reversal drug naloxone, which she had kept in the home because of his history of drug use, but he could not be revived.
An autopsy conducted by the San Francisco Office of the Chief Medical Examiner found that he had died of a combination of substances, among them cychlorphine, a synthetic opioid that city health officials say can be up to ten times more potent than fentanyl and is not detected by standard fentanyl test strips. The report also identified another emerging synthetic opioid, N desethyl isotonitazene, and an unapproved benzodiazepine called ethyl bromazolam. His death marked the first time cychlorphine had been confirmed in a San Francisco medical examiner's report.
The case was not widely publicized at the time of his death. It became national news in mid September 2026, when the New York Times, in a report by Heather Knight, and the San Francisco Department of Public Health both drew attention to his death as the city's first confirmed cychlorphine fatality. Local outlets including KRON4, SFist and the San Francisco Chronicle followed with further reporting.
The San Francisco Police Department said it launched a sweeping investigation after his death to determine where the counterfeit pills had come from. Officers traced messages on his phone, identified suspected sources and carried out controlled drug buys before serving search warrants. On September 8 and 9, 2026, police arrested four people on felony charges and seized more than 20,000 counterfeit pills in connection with the case. San Francisco's district attorney, Brooke Jenkins, said the charges filed so far did not establish that any of the four had supplied the specific pill that killed Lacourte, but she said investigators were still working to determine whether the suspects knew cychlorphine was present in the pills and left open the possibility of more serious charges.
City health officials used Lacourte's death to warn the public about cychlorphine's presence in the illicit drug supply, noting that it can require multiple doses of naloxone to reverse an overdose and that even a fraction of a counterfeit pill can be fatal. As of this writing, no memorial service details have been made public, and the Lacourte family has asked mainly that his story be used to warn other parents and teenagers about the dangers of counterfeit pills.
